@article{fe7d4d005db04ae9afd7f2f91afadef2,
title = "A phase 3 trial of bevacizumab in ovarian cancer",
abstract = "Angiogenesis plays a role in the biology of ovarian cancer. We examined the effect of bevacizumab, the vascular endothelial growth factor inhibitor, on survival in women with this disease.",
keywords = "Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Carboplatin, Combined Modality Therapy, Disease-Free Survival, Double-Blind Method, Female, Humans, Middle Aged, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Paclitaxel, Quality of Life, Survival Analysis",
author = "Perren, {Timothy J} and Swart, {Ann Marie} and Jacobus Pfisterer and Ledermann, {Jonathan A} and Eric Pujade-Lauraine and Gunnar Kristensen and Carey, {Mark S} and Philip Beale and Andr{\'e}s Cervantes and Christian Kurzeder and {du Bois}, Andreas and Jalid Sehouli and Rainer Kimmig and Anne St{\"a}hle and Fiona Collinson and Sharadah Essapen and Charlie Gourley and Alain Lortholary and Fr{\'e}d{\'e}ric Selle and Mirza, {Mansoor R} and Arto Leminen and Marie Plante and Dan Stark and Wendi Qian and Parmar, {Mahesh K B} and Oza, {Amit M} and {ICON7 Investigators}",
year = "2011",
month = dec,
doi = "10.1056/NEJMoa1103799",
language = "English",
volume = "365",
pages = "2484--96",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachusetts Medical Society",
number = "26",
}